These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6289709)

  • 41. The effect of ozone inhalation on metabolic functioning of vascular endothelium and on ventilatory function.
    Gross KB; White HJ; Sargent NE
    Toxicol Appl Pharmacol; 1991 Jun; 109(2):336-51. PubMed ID: 1648804
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of flow and surface area on angiotensin-converting enzyme activity in rabbit lungs.
    Moalli R; Pitt BR; Gillis CN
    J Appl Physiol (1985); 1987 May; 62(5):2042-50. PubMed ID: 3036760
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Isolation of rabbit pulmonary microvascular endothelial cells and characterization of their angiotensin converting enzyme activity.
    Carley WW; Tanoue L; Merker M; Gillis CN
    Pulm Pharmacol; 1990; 3(1):35-40. PubMed ID: 1966901
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of ketamine and fentanyl on lung metabolism in perfused rat lungs.
    Martin DC; Carr AM; Livingston RR; Watkins CA
    Am J Physiol; 1989 Sep; 257(3 Pt 1):E379-84. PubMed ID: 2551177
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lung angiotensin-converting enzyme kinetics from indicator-dilution and constant-infusion methods.
    Linehan JH; Bongard RD; Roerig DL; Bronikowski TA; Dawson CA
    Am J Physiol; 1990 Feb; 258(2 Pt 2):H436-44. PubMed ID: 2155544
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pulmonary capillary endothelium-bound angiotensin-converting enzyme activity in humans.
    Orfanos SE; Langleben D; Khoury J; Schlesinger RD; Dragatakis L; Roussos C; Ryan JW; Catravas JD
    Circulation; 1999 Mar; 99(12):1593-9. PubMed ID: 10096936
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enflurane, halothane and isoflurane do not inhibit angiotensin converting enzyme activity.
    Alifimoff JK; Brandom BW; Cook DR
    Can Anaesth Soc J; 1985 Jul; 32(4):351-7. PubMed ID: 2992730
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Angiotensin-converting enzyme kinetics in an endothelial cell column.
    Howell RE; Haselton FR; Mueller SN
    Am J Physiol; 1990 Apr; 258(4 Pt 1):L188-94. PubMed ID: 2159223
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Indicator dilution measurement of 5-hydroxytryptamine clearance by human lung.
    Gillis CN; Cronau LH; Mandel S; Hammond GL
    J Appl Physiol Respir Environ Exerc Physiol; 1979 Jun; 46(6):1178-83. PubMed ID: 381261
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Environmental influences on uptake of serotonin and other amines.
    Fisher AB; Block ER; Pietra G
    Environ Health Perspect; 1980 Apr; 35():191-8. PubMed ID: 7408797
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of angiotensin-converting enzyme substrate conformation on fractional hydrolysis in lung.
    Merker MP; Armitage IM; Audi SH; Kakalis LT; Linehan JH; Maehl JR; Roerig DL; Dawson CA
    Am J Physiol; 1996 Feb; 270(2 Pt 1):L251-9. PubMed ID: 8779994
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enflurane, halothane, and isoflurane inhibit removal of 5-hydroxytryptamine from the pulmonary circulation.
    Cook DR; Brandom BW
    Anesth Analg; 1982 Aug; 61(8):671-5. PubMed ID: 7201270
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vivo determinations of Ki values for angiotensin converting enzyme inhibitors.
    Catravas JD; Anthony BL
    Adv Exp Med Biol; 1986; 198 Pt A():453-9. PubMed ID: 3028064
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quantification of pulmonary capillary endothelium-bound angiotensin converting enzyme inhibition in man.
    Cziraki A; Horvath I; Rubin JW; Theodorakis M; Catravas JD
    Gen Pharmacol; 2000 Oct; 35(4):213-8. PubMed ID: 11827728
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Single-pass removal of [14C]-5-hydroxytryptamine and [3H]norepinephrine by rabbit lung, in vivo: kinetics and sites of removal.
    Catravas JD; Gillis CN
    J Pharmacol Exp Ther; 1983 Jan; 224(1):28-33. PubMed ID: 6848747
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Propranolol and serotonin removal in lung injury.
    Merker MP; Gillis CN
    J Appl Physiol (1985); 1988 Dec; 65(6):2579-84. PubMed ID: 3063711
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lung MK 351A uptake after hypoxia adaptation and subsequent hyperoxia exposure.
    Jackson RM; Ann HS; Oparil S
    Lung; 1988; 166(4):209-19. PubMed ID: 2849698
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of hypoxia and hypercapnia on ACE activity in the cerebral microcirculation of anesthetized dogs.
    Pitt BR; Lister G; Dawson CA; Linehan JH
    Am J Physiol; 1986 May; 250(5 Pt 2):H806-14. PubMed ID: 3010743
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pulmonary extraction of [3H]bupivacaine: modification by dose, propranolol and interaction with [14C]5-hydroxytryptamine.
    Rothstein P; Cole JS; Pitt BR
    J Pharmacol Exp Ther; 1987 Feb; 240(2):410-4. PubMed ID: 3806406
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lisinopril and ramiprilat protection of the vascular endothelium against free radical-induced functional injury.
    Gillis CN; Chen X; Merker MM
    J Pharmacol Exp Ther; 1992 Jul; 262(1):212-6. PubMed ID: 1320684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.